Kolexia
Tavitian Suzanne Hématologie
Tavitian Suzanne
Hématologie
Oncopole Toulouse
Toulouse, France
133 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Anémie Hémoglobinurie Leucémie-lymphome lymphoblastique à précurseurs B et T Hémoglobinurie paroxystique Syndromes myéloprolifératifs Anémie aplasique

Collaborateurs

Voir plus
Recher Christian
Recher Christian
Hôpital Purpan, Toulouse, France
Bertoli Sarah
Bertoli Sarah
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Huguet Francoise
Huguet Francoise
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Delabesse Eric
Delabesse Eric
Oncopole Toulouse, Toulouse, France

Industries

Voir plus
Novartis
7 collaboration(s)
Dernière en 2023
Servier
2 collaboration(s)
Dernière en 2023
Pfizer
2 collaboration(s)
Dernière en 2021
Incyte
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Cancer medicine   26 février 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
Leukemia research   09 janvier 2024
Atgam Efficacy and Safety in Moderate-to-Very Severe Acquired Aplastic Anemia: Outcome of a Large Multicenter Cohort of 634 Children and Adults from the French Authorization for Temporary Use Surveillance Program
65th ASH Annual Meeting Abstracts   02 novembre 2023
Levofloxacin to Prevent Bacterial Infection in Patients with Acute Myeloid Leukemia Treated By Azacitidine and Venetoclax: A Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1: Time to Reconsider Prognostic Risk? a Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
Venetoclax and Azacitidine for Molecular Relapse during First Line Intensive Chemotherapy in Patients with NPM1 Mutated or Core Binding Factor (CBF) AML. a Study from the Dataml Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Vitamin C and D Supplementation in Acute Myeloid Leukemia.
Blood advances   06 septembre 2023
MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023